Cargando…

JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox — United States, May 22, 2022–January 31, 2023

Detalles Bibliográficos
Autores principales:	Owens, Lauren E., Currie, Dustin W., Kramarow, Ellen A., Siddique, Safana, Swanson, Megan, Carter, Rosalind J., Kriss, Jennifer L., Boersma, Peter M., Lee, Florence C., Spicknall, Ian, Hurley, Elizabeth, Zlotorzynska, Maria, Gundlapalli, Adi V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078841/ https://www.ncbi.nlm.nih.gov/pubmed/36995962 http://dx.doi.org/10.15585/mmwr.mm7213a4

Ejemplares similares

Potential for Recurrent Mpox Outbreaks Among Gay, Bisexual, and Other Men Who Have Sex with Men — United States, 2023
por: Pollock, Emily D., et al.
Publicado: (2023)

Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
por: Payne, Amanda B., et al.
Publicado: (2022)

Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023
por: Dalton, Alexandra F., et al.
Publicado: (2023)

Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022
por: Kriss, Jennifer L., et al.
Publicado: (2022)

Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022
por: Payne, Amanda B., et al.
Publicado: (2022)

Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine — California, May 2022–May 2023
por: Schildhauer, Samuel, et al.
Publicado: (2023)

Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection — New York, 2022
por: Rosenberg, Eli S., et al.
Publicado: (2023)

Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
por: Duffy, Jonathan, et al.
Publicado: (2022)

Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis — United States, May 2022–April 2023
por: Kota, Krishna Kiran, et al.
Publicado: (2023)

The CDC Domestic Mpox Response — United States, 2022–2023
por: McQuiston, Jennifer H., et al.
Publicado: (2023)

Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January–March 2023
por: Mizushima, Daisuke, et al.
Publicado: (2023)

Clinical, epidemiological, and virological features of Mpox in Beijing, China – May 31–June 21, 2023
por: Dou, Xiangfeng, et al.
Publicado: (2023)

Racial and Ethnic Disparities in Mpox Cases and Vaccination Among Adult Males — United States, May–December 2022
por: Kota, Krishna Kiran, et al.
Publicado: (2023)

1778. Same Story, Different Outbreak: Lessons from a Survey Study Investigating JYNNEOS Mpox Public Vaccination Clinic Establishment in New Hampshire
por: Kang, HeeEun, et al.
Publicado: (2023)

Overview of Mpox Outbreak in Greece in 2022–2023: Is It Over?
por: Mellou, Kassiani, et al.
Publicado: (2023)

In the Literature: January 2023
por: Martín-Arana, J., et al.
Publicado: (2023)

January 2023 obituaries
Publicado: (2023)

Demographic Disparities in Mpox Vaccination Series Completion, by Route of Vaccine Administration — California, August 9, 2022–March 31, 2023
por: Salih, Tarek, et al.
Publicado: (2023)

Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023
por: Hoxha, Ana, et al.
Publicado: (2023)

Tecovirimat Resistance in Mpox Patients, United States, 2022–2023
por: Smith, Todd G., et al.
Publicado: (2023)

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022
por: Farrar, Jennifer L., et al.
Publicado: (2022)

Inaugural Editorial, January 2023
por: Gaut, Brandon S, et al.
Publicado: (2023)

Editors’ Pick in January 2023
por: Yang, Hee-Jin, et al.
Publicado: (2023)

Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2022)

PUBLIC MEETING - January 2023 - Recording
por: Staff Association
Publicado: (2023)

Salary Scale 1 January 2023
por: Stappers, Sara
Publicado: (2023)

Actuarial dashboard as at 1 January 2023
Publicado: (2023)

JHEP at a glance (January 2023)
Publicado: (2023)

SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020–31 January 2023
por: Cegolon, Luca, et al.
Publicado: (2023)

Epidemiologic and Clinical Features of Mpox-Associated Deaths — United States, May 10, 2022–March 7, 2023
por: Riser, Aspen P., et al.
Publicado: (2023)

JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study
por: Lee, Jaeeun, et al.
Publicado: (2023)

2023 January issue Journal of Orthopaedic Translation
por: Xiao, Guozhi
Publicado: (2023)

Human vaccines & immunotherapeutics: News January 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Interim Clinical Treatment Considerations for Severe Manifestations of Mpox — United States, February 2023
por: Rao, Agam K., et al.
Publicado: (2023)

Notes from the Field: Emergence of an Mpox Cluster Primarily Affecting Persons Previously Vaccinated Against Mpox — Chicago, Illinois, March 18–June 12, 2023
por: Faherty, Emily A. G., et al.
Publicado: (2023)

FDA's authorized “JYNNEOS” vaccine for counteracting monkeypox global public health emergency; an update – Correspondence
por: Sah, Ranjit, et al.
Publicado: (2022)

Financial Situation as on January 31,1954
Publicado: (1954)

Recommendations of meeting of 31 January 1967
por: CERN. Geneva. Physics III Committee
Publicado: (1967)

Beware 31 January tax pitfalls
Publicado: (2020)

In this issue: Volume 114, Issue 1, January 2023
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n5kqniscicdv1331iqmenht35i